Greiner Bio-One is pleased to present the fourth edition of bioLOGICAL, its client magazine. Enjoy the exciting contents and gain some insights into the subjects that have kept us busy in 2020.
This issue deals with the topics that have been of special relevance to us in 2020: the new coronavirus (Sars-CoV-2) and sustainability in the field of medical technology and life science.
We provide you with an insight into the antibody test procedure of SARS-CoV-2 and indicate the stages of this where Greiner Bio-One products can also play a decisive role. We have also been able to launch an important new product during the crisis: The virus stabilisation tube. We inter-view Moritz Wiesbauer, Team Leader Physical Testing and Change Control at Greiner Bio-One, who answers questions on development and what the company can learn from the crisis.
Find out why plastic is indispensable in medical technology and what advantages it has for the industry compared with other materials, for example. Blue Plan is Greiner AG‘s sustainability strategy, which also gives rise to measures for Greiner Bio-One. Stefan Grafenhorst, Head of Sustainability and Corporate Responsibility, Greiner AG, answers five interesting questions about sustainability and the Blue Plan.
To request the magazine, please fill out the enquiry form attached to this page.